StonvexLoading…
StonvexStonvexStonvexCore line items from GBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $1.29B | $706.10M | $3.24B | $2.48B |
Operating Income | $86.20M | $61.10M | $360.10M | $288.00M |
Net Income | $51.40M | $36.40M | $204.10M | $167.30M |
EPS (Diluted) | $1.62 | $1.14 | $6.35 | $5.18 |
Total Assets | $4.34B | $4.30B | $4.36B | $4.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $521.80M | $361.80M | $306.10M | $296.80M |
Free Cash Flow OCF − CapEx | $147.30M | $18.70M | $-14.70M | $-41.40M |
Shares Outstanding | 30.94M | 30.90M | 30.87M | 30.88M |